Integra Lifesciences Holdings (IART) Debt to Equity (2009 - 2026)
Integra Lifesciences Holdings recorded quarterly Debt to Equity of $1.72 in Q1 2026, up 1.27% quarter-over-quarter from $1.69 in Q4 2025, and up 124.09% year-over-year from $0.77 in Q1 2025.
Integra Lifesciences Holdings' Debt to Equity history runs 18 years deep, the most recent figure standing at $1.72 for Q1 2026.
- In Q1 2026, Debt to Equity rose 124.09% year-over-year to $1.72; the TTM figure through Mar 2026 stood at $1.72 (up 124.09% YoY), while the FY2025 annual figure was $1.69, up 57.65% from the prior year.
- Debt to Equity came in at $1.72 for Q1 2026 at Integra Lifesciences Holdings, up from $1.69 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $1.72 in Q1 2026 to a low of $0.43 in Q4 2022.
- A 5-year average of $0.84 and a median of $0.74 in 2024 frame the typical range for Debt to Equity.
- Across the five-year window, Debt to Equity declined 17.15% in 2022 and jumped 124.09% in 2026, its largest moves.
- Integra Lifesciences Holdings' Debt to Equity stood at $0.43 in 2022, then grew by 21.63% to $0.52 in 2023, then jumped by 106.75% to $1.07 in 2024, then soared by 57.65% to $1.69 in 2025, then rose by 1.27% to $1.72 in 2026.
- According to Business Quant data, Debt to Equity over the past three periods registered $1.72, $1.69, and $1.65 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.65 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.64 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.57 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.42 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.06 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.95 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.27 |
| 10 | Integra Lifesciences Holdings | 1.20 Bn | 939.16 Mn | 216.98 Mn | 1.72 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.72 |
| Dec 31, 2025 | 1.69 |
| Sep 30, 2025 | 1.65 |
| Jun 30, 2025 | 1.11 |
| Mar 31, 2025 | 0.77 |
| Dec 31, 2024 | 1.07 |
| Sep 30, 2024 | 0.76 |
| Jun 30, 2024 | 0.77 |
| Mar 31, 2024 | 0.74 |
| Dec 31, 2023 | 0.52 |
| Sep 30, 2023 | 0.54 |
| Jun 30, 2023 | 0.46 |
| Mar 31, 2023 | 0.46 |
| Dec 31, 2022 | 0.43 |
| Sep 30, 2022 | 0.50 |
| Jun 30, 2022 | 0.52 |
| Mar 31, 2022 | 0.54 |
| Dec 31, 2021 | 0.52 |
| Sep 30, 2021 | 0.53 |
| Jun 30, 2021 | 0.55 |
| Mar 31, 2021 | 0.63 |
| Dec 31, 2020 | 0.64 |
| Sep 30, 2020 | 0.69 |
| Jun 30, 2020 | 0.75 |
| Mar 31, 2020 | 0.76 |
| Dec 31, 2019 | 0.88 |
| Sep 30, 2019 | 0.95 |
| Jun 30, 2019 | 0.88 |
| Mar 31, 2019 | 0.89 |
| Dec 31, 2018 | 0.90 |
| Sep 30, 2018 | 1.04 |
| Jun 30, 2018 | 1.10 |
| Mar 31, 2018 | 1.83 |
| Dec 31, 2017 | 1.87 |
| Sep 30, 2017 | 1.28 |
| Jun 30, 2017 | 0.98 |
| Mar 31, 2017 | 1.04 |
| Dec 31, 2016 | 0.79 |
| Sep 30, 2016 | 0.56 |
| Jun 30, 2016 | 0.61 |
| Mar 31, 2016 | 0.66 |
| Dec 31, 2015 | 0.66 |
| Sep 30, 2015 | 0.70 |
| Jun 30, 2015 | 0.61 |
| Mar 31, 2015 | 0.58 |
| Dec 31, 2014 | 0.59 |
| Sep 30, 2014 | 0.60 |
| Jun 30, 2014 | 0.61 |
| Mar 31, 2014 | 0.62 |
| Dec 31, 2013 | 0.28 |
| Sep 30, 2013 | 0.68 |
| Jun 30, 2013 | 0.66 |
| Mar 31, 2013 | 0.63 |
| Dec 31, 2012 | 0.62 |
| Sep 30, 2012 | 0.61 |
| Jun 30, 2012 | 0.63 |
| Mar 31, 2012 | 0.33 |
| Dec 31, 2011 | 0.36 |
| Sep 30, 2011 | 0.38 |
| Jun 30, 2011 | 0.28 |
| Mar 31, 2011 | 0.39 |
| Dec 31, 2010 | 0.50 |
| Sep 30, 2010 | 0.45 |
| Jun 30, 2010 | 0.48 |
| Dec 31, 2009 | 0.53 |